rs397507448
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_024312.5(GNPTAB):c.1399delG(p.Asp467IlefsTer33) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000446 in 1,614,016 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_024312.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- GNPTAB-mucolipidosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- mucolipidosisInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
- mucolipidosis type IIInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, Genomics England PanelApp
- mucolipidosis type III, alpha/betaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, G2P, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_024312.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GNPTAB | NM_024312.5 | MANE Select | c.1399delG | p.Asp467IlefsTer33 | frameshift | Exon 11 of 21 | NP_077288.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GNPTAB | ENST00000299314.12 | TSL:1 MANE Select | c.1399delG | p.Asp467IlefsTer33 | frameshift | Exon 11 of 21 | ENSP00000299314.7 | ||
| GNPTAB | ENST00000549940.5 | TSL:1 | c.1399delG | p.Asp467IlefsTer8 | frameshift | Exon 11 of 11 | ENSP00000449150.1 | ||
| GNPTAB | ENST00000552009.1 | TSL:3 | n.58delG | non_coding_transcript_exon | Exon 1 of 2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152174Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 251428 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000465 AC: 68AN: 1461842Hom.: 0 Cov.: 31 AF XY: 0.0000536 AC XY: 39AN XY: 727224 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152174Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74344 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Pseudo-Hurler polydystrophy;C2673377:Mucolipidosis type II Pathogenic:3
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
This sequence change creates a premature translational stop signal (p.Asp467Ilefs*33) in the GNPTAB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GNPTAB are known to be pathogenic (PMID: 19617216, 25107912). This variant is present in population databases (rs397507448, gnomAD 0.004%). This premature translational stop signal has been observed in individuals with mucolipidosis II and III alpha/beta (PMID: 19617216, 19634183, 28396763). ClinVar contains an entry for this variant (Variation ID: 39034). For these reasons, this variant has been classified as Pathogenic.
Mucolipidosis type II Pathogenic:1Other:1
Mucolipidosis Pathogenic:1
Variant summary: GNPTAB c.1399delG (p.Asp467IlefsX33) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 2e-05 in 251428 control chromosomes (gnomAD). The variant, c.1399delG, has been reported in the literature in compound heterozygosity and in homozygous form, in several individuals affected with Mucolipidosis (e.g. Tappino_2009, Cathey_2010, Wood_2017). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.
not provided Pathogenic:1
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 20301728, 25107912, 19617216, 19634183, 28396763, 24045841)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at